IAA
GSK icon

Ironsides Asset Advisors’s GSK GSK Stock Holding History

Ironsides Asset Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,689
Closed -$255K – 152
2016
Q3 		$255K Buy
4,689
+609
+15% +$33.4K 0.07% 142
2016
Q2 		$224K Sell
4,080
-1,247
-23% -$65.7K 0.07% 134
2016
Q1 		$278K Buy
5,327
+927
+21% +$46.2K 0.07% 153
2015
Q4 		$225K Sell
4,400
-320
-7% -$16.3K 0.06% 141
2015
Q3 		$230K Hold
4,720
– – 0.06% 143
2015
Q2 		$246K Buy
4,720
+400
+9% +$22.5K 0.07% 137
2015
Q1 		$249K Hold
4,320
– – 0.07% 137
2014
Q4 		$231K Buy
+4,320
New +$242K 0.06% 144

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ironsides Asset Advisors's GSK Position: Q4 2016 in Review

Ironsides Asset Advisors sold out of GSK (GSK) in Q4 2016, closing a stake of 4,689 shares — an estimated $255K sold.

Ironsides Asset Advisors first reported a position in GSK in Q4 2014 and held it in 8 quarters. The position peaked at $278K in Q1 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Ironsides Asset Advisors reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Ironsides Asset Advisors sold 4,689 GSK shares in Q4 2016, an estimated $255K.
  • Ironsides Asset Advisors first reported a position in GSK in Q4 2014 and held it in 8 quarters.
  • Ironsides Asset Advisors's GSK position peaked at $278K in Q1 2016.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Ironsides Asset Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.